PHARMACOECONOMIC EFFICIENCY OF QUADRIVALENT VACCINE TO PREVENT HPV-ASSOCIATED DISEASES
Human papilloma virus (HPV) infection is a major challenge to modern health care. At the moment there is only one way to effectively prevent diseases associated with HPV. There is vaccination. The available vaccines prevent most cases of HPVassociated diseases and can significantly reduce the financ...
Main Author: | I. A. DYAKOV |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2016-12-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/1635 |
Similar Items
-
Vaccine and Non-Vaccine HPV Types Presence in Adolescents with Vertically Acquired HIV Five Years Post Gardasil Quadrivalent Vaccination: The ZIMGARD Cohort
by: Alltalents T. Murahwa, et al.
Published: (2024-01-01) -
A comprehensive narrative review of challenges and facilitators in the implementation of various HPV vaccination program worldwide
by: Sumit Aggarwal, et al.
Published: (2024-02-01) -
Neuromyotonia with Central Nervous System Lesions following Quadrivalent Human Papilloma Virus Vaccination
by: Maryam Hatami, et al.
Published: (2022-07-01) -
Human Papilloma Virus Vaccination
by: Kendal Rosalik, et al.
Published: (2021-06-01) -
A case of acute disseminated encephalomyelitis following human papillomavirus quadrivalent vaccination
by: Mina Lee, et al.
Published: (2022-04-01)